Document is current
Any future updates will be listed below
-
Authors
Parvez, E.
Bogach, J.
Kirkwood, D.
Pond, G.
Doumouras, A.
Hodgson, N.
Levine, M.
-
Funding
Funding for this research was provided by:
Hamilton Health Sciences Foundation (W.E. Noonan Fellowship)
- License Information
-
More Information
Article History
Received: 8 January 2024
Accepted: 19 March 2024
First Online: 18 April 2024
Disclosures
: Dr. Gregory Pond, Consulting fees from Astra-Zeneca, Merck, and Profound Medical. I have received honorarium for DSMB membership from Takeda. Close family member who is employed by Roche Canada and who owns Roche stock.
: The use of the data in this project is authorized under section 45 of Ontario’s Personal Health Information Protection Act (PHIPA) and does not require review by a Research Ethics Board.
